GraniteShares Advisors’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
GraniteShares Advisors's RMD Position: Q2 2026 in Review
GraniteShares Advisors reduced its ResMed (RMD) stake by 7.1% in Q2 2026, selling an estimated $36.5K and leaving 2,320 shares worth $452K. The position accounts for 0.29% of the portfolio, ranked #76.
GraniteShares Advisors first reported a position in RMD in Q4 2021 and has held it in 9 quarters since. The position peaked at $705K in Q3 2025. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- GraniteShares Advisors held 2,320 shares of ResMed worth $452K as of Q2 2026.
- GraniteShares Advisors sold 176 ResMed shares in Q2 2026, an estimated $36.5K.
- ResMed made up 0.29% of GraniteShares Advisors's portfolio in Q2 2026, its #76 holding.
- GraniteShares Advisors first reported a position in ResMed in Q4 2021 and has held it in 9 quarters since.
- GraniteShares Advisors's ResMed position peaked at $705K in Q3 2025.
- 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on GraniteShares Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.